“…These include 18 F-labelled 2-nitroimidazoles such as [ 18 F]FMISO (Koh et al, 1995;Rasey et al, 1996), [ 18 F]EF5 (Ziemer et al, 2003), [ 18 F]FETNIM (Yang et al, 1995), [ 18 F]FAZA (Sorger et al, 2003), and N-(2-([ 18 F]fluoroethyl)-2-(2-nitroimidazol-1-yl)-acetamide ([ 18 F]FETA) (Rasey et al, 1999); copper bis-thiosemi-carbazones such as [ 60 Cu]ATSM (Fujibayashi et al, 1997;Dehdashti et al, 2003); technetium-based probes such as [ 99m Tc]HL-91 (Honess et al, 1998); and iodine-based probes such as [ 123 I]IAZA (Mannan et al, 1991). Due to various limitations, none of these radiotracers have found their way into routine clinical use (Workman and Brown, 1981;Nunn et al, 1995;Rasey et al, 1999;Bentzen et al, 2002).…”